Concomitant and adjuvant androgen deprivation (ADT) with external beam irradiation (RT) for locally advanced prostate cancer: 6 months versus 3 years ADT-Results of the randomized EORTC Phase III trial 22961

被引：0
|
作者：
Bolla, M.
van Tienhoven, G.
de Reijke, T. M.
van den Bergh, A. C.
van der Meijden, A. P.
Poortmans, P. M.
Gez, E.
Kil, P.
Pierart, M.
Collette, L.
机构：
[1] Ctr Hosp Reg Grenoble, Grenoble, France
[2] Acad Med Ctr, Amsterdam, Netherlands
[3] Univ Med Ctr Groningen, Groningen, Netherlands
[4] Jeroen Bosch Ziekenhuis, Shertogenbosch, Netherlands
[5] Doctor Bernard Verbeeten Inst, Tilburg, Netherlands
[6] Rambam Med Ctr, Haifa, Israel
[7] Sint Elisabethziekenhuis, Tilburg, Netherlands
[8] EORTC Data Ctr, Brussels, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5014
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PSA response and early PSA progression evaluated in patients randomized in a phase III trial comparing androgen deprivation therapy (ADT) plus docetaxel versus ADT alone in hormone-naive metastatic prostate cancer (GETUG-AFU 15/0403).
    Gravis, G.
    Fizazi, K.
    Joly, F.
    Oudard, S.
    Priou, F.
    Latorzeff, I.
    Delva, R.
    Esterni, B.
    Habibian, M.
    Soulie, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] Androgen deprivation therapy (ADT) plus docetaxel (D) versus ADT alone for hormone-naive metastatic prostate cancer (PCa): Long-term analysis of the GETUG-AFU 15 phase III trial.
    Gravis, Gwenaelle
    Boher, Jean-Marie
    Joly, Florence
    Oudard, Stephane
    Albiges, Laurence
    Priou, Franck
    Latorzeff, Igor
    Delva, Remy
    Krakowski, Ivan
    Laguerre, Brigitte
    Rolland, Frederic
    Theodore, Christine
    Deplanque, Gael
    Ferrero, Jean-Marc
    Pouessel, Damien
    Mourey, Loic
    Beuzeboc, Philippe
    Habibian, Muriel
    Soulie, Michel
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [23] Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial
    Malone, Shawn
    Roy, Soumyajit
    Eapen, Libni
    Choan, E.
    MacRae, Robert
    Perry, Gad
    Bowen, Julie
    Samant, Rajiv
    Morgan, Scott
    Craig, Julia
    Malone, Kyle
    Grimes, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06) : 593 - +
  • [24] PSA response and early PSA progression evaluated in patients randomized in a phase III trial comparing androgen-deprivation therapy (ADT) plus docetaxel versus ADT alone in hormone-naive metastatic prostate cancer (GETUG-AFU 15/0403)
    Gravis, G.
    Fizazi, K.
    Joly, F.
    Oudard, S.
    Priou, F.
    Latorzeff, I.
    Delva, R.
    Esterni, B.
    Habibian, M.
    Soulie, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [25] Is long-term survival in Glioblastoma possible? Updated results of the EORTC/NCIC phase III randomized trial on radiotherapy (RT) and concomitant and adjuvant Temozolomide (TMZ) versus RT alone
    Mirimanoffr, R.
    Mason, W.
    Van den Bent, M.
    Kortmann, R.
    Taphoorn, M.
    Brandes, A.
    Villa, S.
    Cairncrosss, G.
    Gorlia, T.
    Stupp, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S2 - S2
  • [26] LONG-TERM ANDROGEN DEPRIVATION, WITH OR WITHOUT RADIOTHERAPY, IN LOCALLY-ADVANCED PROSTATE CANCER: RESULTS FROM A PHASE III RANDOMIZED STUDY
    Sargos, Paul
    Mottet, Nicolas
    Richaud, Pierre
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1361 - E1361
  • [27] Long-term androgen deprivation, with or without radiotherapy, in locally advanced prostate cancer: updated results from a phase III randomised trial
    Sargos, Paul
    Mottet, Nicolas
    Bellera, Carine
    Richaud, Pierre
    BJU INTERNATIONAL, 2020, 125 (06) : 810 - 816
  • [28] Final analysis of intergroup randomized phase III study of androgen deprivation therapy (ADT) plus radiation therapy (RT) in locally advanced prostate cancer (CaP) (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110)
    Mason, Malcolm David
    Parulekar, Wendy
    Sydes, Matthew Robert
    Parmar, Mahesh
    Anderson, John
    Barber, Jim
    Brundage, Michael Donald
    Cowan, Richard
    Gospodarowicz, Mary K.
    Hayter, Charles
    Hetherington, John
    Hiltz, Andrea Clare
    Kirkbride, Peter
    Kostashuk, Edward
    Sanders, Karen
    Sathya, Jinka
    Swanson, Gregory P.
    Chen, Bingshu E.
    Warde, Padraig Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Post radical prostatectomy (RP) PSA outcomes following 6 vs 18 months of perioperative androgen deprivation therapy (ADT) in men with localized high risk prostate cancer (LHRPC): Results of Part 2 of a randomized phase 2 trial
    McKay, Rana R.
    Xie, Wanling
    Yang, Xiaoyu
    Rathkopf, Dana E.
    Laudone, Vincent Paul
    Bubley, Glenn
    Einstein, David Johnson
    Chang, Peter
    Wagner, Andrew
    Kane, Christopher J.
    Parsons, J. Kellogg
    Preston, Mark A.
    Kilbridge, Kerry L.
    Chang, Steven Lee
    Choudhury, Atish Dipankar
    Quoc-Dien Trinh
    Pomerantz, Mark
    Kibel, Adam S.
    Taplin, Mary Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] EORTC trial 22991: Results of a phase III study comparing 6 months of androgen suppression and irradiation versus irradiation alone for localized T1b-cT2aN0M0 prostate cancer
    Bolla, Michel
    Van den Bergh, Alphonsus C. M.
    Carrie, Christian
    Villa, Salvador
    Kitsios, Petros
    Poortmans, Philip M.
    Sundar, Santhanam
    van der Steen-Banasik, Elzbieta M.
    Armstrong, John
    Bosset, Jean-Francois
    Herrera, Fernanda
    Pieters, Bradley
    Slot, Annerie
    Bahl, Amit
    Collette, Laurence
    Maingon, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345